RIGImmune is a biopharmaceutical company developing a new class of immune modulating therapies for diseases caused by RNA viruses and antitumor immune response induction. Our therapeutic candidates are designed to ameliorate a broad spectrum of disease conditions and therapeutic outcomes arising from viral infections and certain cancers. The RIGImmune development candidates could also benefit vaccines for multiple viral respi...
RIGImmune is a biopharmaceutical company developing a new class of immune modulating therapies for diseases caused by RNA viruses and antitumor immune response induction. Our therapeutic candidates are designed to ameliorate a broad spectrum of disease conditions and therapeutic outcomes arising from viral infections and certain cancers. The RIGImmune development candidates could also benefit vaccines for multiple viral respiratory infections as adjuvants or boosters.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.